Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$735,266
+$31,933 QoQ
Shares Held
6,220
+11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$338,420
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CSS LLC/IL holds $5,129,429 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,757 | $1,634,845 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
6,950 | $915,593 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
27,070 | $815,348 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
37,616 | $780,908 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
6,220 | $735,266 | |
| 6 | VTRS |
Viatris Inc
|
8,520 | $115,105 | |
| 7 | YCBD |
cbdMD, Inc.
|
137,621 | $102,114 | |
| 8 | EVO |
Evotec SE
|
12,100 | $30,250 |
All Filings in ZTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $735,266 | 6,220 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $703,333 | 5,590 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $338,420 | 2,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $986,850 | 5,000 | Put | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||